
Sky Bio-Pharma (India ) Limited
Manufactures and trades in various chemicals and pharmaceutical products.
Manufactures and trades in various chemicals and pharmaceutical products.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
-
U24110MH2002PLC134562
134562
Public Limited Indian Non-Government Company
15 Jan 2002
29 Sep 2017
31 Mar 2017
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vinod Vyas ![]() | Director | 15-Jan-2002 | Current |
Durgesh Chandavarkar ![]() | Director | 15-Jan-2002 | Current |
Vijay Vyas ![]() | Director | 16-Mar-2015 | Current |
Dhruv Vyas ![]() | Director | 16-Mar-2015 | Current |
Haresh Vyas ![]() | Director | 15-Jan-2002 | Current |
Ketan Vyas ![]() | Director | 24-Dec-2002 | Current |
Sky Bio-Pharma (India ) Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 542.91% increase. The company also saw a substantial improvement in profitability, with a 767.37% increase in profit. The company's net worth Soared by an impressive increase of 55.95%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Sky Bio-Pharma (India ) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Vinod Vyas, Durgesh Chandavarkar and 1 more are mutual person
Vinod Vyas and Durgesh Chandavarkar are mutual person
Vinod Vyas, Durgesh Chandavarkar and 5 more are mutual person
Ketan Vyas is a mutual person
Durgesh Chandavarkar, Dhruv Vyas and 2 more are mutual person
Vinod Vyas, Durgesh Chandavarkar and 5 more are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sky Bio-Pharma (India ), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sky Bio-Pharma (India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky Bio-Pharma (India )'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sky Bio-Pharma (India ) Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.
29 Sep 2017
Sky Bio-Pharma (India ) Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai.
31 Mar 2017
Vijay Chunilal Vyas was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 9 years 11 months .
16 Mar 2015
Dhruv Somalal Vyas was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 9 years 11 months .
16 Mar 2015
Bharat Chunilal Vyas was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 9 years 11 months .
16 Mar 2015
Jitendra Garganarayan Goswami was appointed as a Director was appointed as a Director on 06 Mar 2003 & has been associated with this company since 21 years 11 months .
06 Mar 2003
Sky Bio-Pharma (India ) Limited was incorporated on 15 Jan 2002.
The authorized share capital of Sky Bio-Pharma (India ) Limited is ₹ 2.50 M and paid-up capital is ₹ 1.00 M.
Currently 8 directors are associated with Sky Bio-Pharma (India ) Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sky Bio-Pharma (India ) Limited is 101 Ketan Apartments233 R B Mehta Marg Patel Chowk Ghatkopar (E) India, Mumbai, Maharashtra, 400077.
The corporate identification number (CIN) of Sky Bio-Pharma (India ) Limited is U24110MH2002PLC134562 and the company number is 134562 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2016, the revenue trend for Sky Bio-Pharma (India ) Limited has risen by 542.91%.
The financial reports for the fiscal year 2016 indicates that The net worth of Sky Bio-Pharma (India ) Limited has experienced an upsurge of 55.95%.
The most recent Balance Sheet for Sky Bio-Pharma (India ) Limited was filed with the ROC on 31 Mar 2017.